Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ovarian cancer: is the news good enough?
Poveda A. Poveda A. Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:298-306. doi: 10.1111/j.1525-1438.2005.00445.x. Int J Gynecol Cancer. 2005. PMID: 16343247 Free article. Review.
Ovarian cancer treatment: what is new.
Poveda A. Poveda A. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:241-50. doi: 10.1111/j.1525-1438.2003.13368.x. Int J Gynecol Cancer. 2003. PMID: 14656286 Review.
Update in the management of ovarian and cervical carcinoma.
Poveda A, Salazar R, del Campo JM, Mendiola C, Cassinello J, Ojeda B, Arranz JA, Oaknin A, García-Foncillas J, Rubio MJ, González Martín A. Poveda A, et al. Clin Transl Oncol. 2007 Jul;9(7):443-51. doi: 10.1007/s12094-007-0083-7. Clin Transl Oncol. 2007. PMID: 17652058
Ten years of "Optimal Therapy in Advanced Ovarian Cancer. Update" meeting.
Poveda A. Poveda A. Int J Gynecol Cancer. 2008 Mar-Apr;18 Suppl 1:67-70. doi: 10.1111/j.1525-1438.2007.01162.x. Int J Gynecol Cancer. 2008. PMID: 18336404
The International Symposium on Advanced Ovarian Cancer: Optimal Therapy was founded by Dr. Andres Poveda and Prof. Jan B. Vermorken, and each edition has been directed by them. ...Last year, almost three hundred people coming not only from Spain but also from Europe, North …
The International Symposium on Advanced Ovarian Cancer: Optimal Therapy was founded by Dr. Andres Poveda and Prof. Jan B. Vermorken, …
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes.
Pecorelli S, Ray-Coquard I, Tredan O, Colombo N, Parma G, Tisi G, Katsaròs D, Lhommé C, Lissoni AA, Vermorken JB, du Bois A, Poveda A, Frigerio L, Barbieri P, Carminati P, Brienza S, Guastalla JP. Pecorelli S, et al. Among authors: poveda a. Ann Oncol. 2010 Apr;21(4):759-765. doi: 10.1093/annonc/mdp514. Epub 2009 Nov 11. Ann Oncol. 2010. PMID: 19906760 Free PMC article. Clinical Trial.
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6-12 months) subpopulation of OVA-301 phase III randomized trial.
Poveda A, Vergote I, Tjulandin S, Kong B, Roy M, Chan S, Filipczyk-Cisarz E, Hagberg H, Kaye SB, Colombo N, Lebedinsky C, Parekh T, Gómez J, Park YC, Alfaro V, Monk BJ. Poveda A, et al. Ann Oncol. 2011 Jan;22(1):39-48. doi: 10.1093/annonc/mdq352. Epub 2010 Jul 19. Ann Oncol. 2011. PMID: 20643862 Free PMC article. Clinical Trial.
253 results